External Validation of the Risk Assessment Model of Venous Thromboembolism in Multicenter Internal Medicine Inpatients

Overview

Journal Clin Appl Thromb Hemost

Publisher Sage Publications

Specialty Cardiology & Vascular Diseases

Date 2024 Apr 18

PMID 38632943

Authors

Xiaolan Chen

Hongning Shi

Jiaqi Chang

Wenjia Guo

Yuanhua Yang

Yong Wang

Lei Pan

Affiliations

Soon will be listed here.

Abstract

To external validate the risk assessment model (RAM) of venous thromboembolism (VTE) in multicenter internal medicine inpatients. We prospectively collected 595 internal medical patients (310 with VTE patients, 285 non-VTE patients) were from Beijing Shijitan Hospital, Beijing Chaoyang Hospital, and the respiratory department of Beijing Tsinghua Changgeng Hospital from January 2022 to December 2022 for multicenter external validation. The prediction ability of Caprini RAM, Padua RAM, The International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) RAM, and Shijitan (SJT) RAM were compared. This study included a total of 595 internal medicine inpatients, including 242 (40.67%) in the respiratory department, 17 (2.86%) in the respiratory intensive care unit, 49 (8.24%) in the neurology department, 34 (5.71%) in the intensive care unit, 26 (4.37%) in the geriatric department, 22 (3.70%) in the emergency department, 71 (11.93%) in the nephrology department, 63 (10.59%) in the cardiology department, 24 (4.03%) in the hematology department, 6 (1.01%) in the traditional Chinese medicine department, 9 (1.51%) cases in the rheumatology department, 7 (1.18%) in the endocrinology department, 14 (2.35%) in the oncology department, and 11 (1.85%) in the gastroenterology department. Multivariate logistic regression analysis showed that among internal medicine inpatients, age > 60 years old, heart failure, nephrotic syndrome, tumors, history of VTE, and elevated D-dimer were significantly correlated with the occurrence of VTE ( < .05). The incidence of VTE increases with the increase of D-dimer. It was found that the effectiveness of SJT RAM (AUC = 0.80 ± 0.03) was better than Caprini RAM (AUC = 0.74 ± 0.03), Padua RAM (AUC = 0.72 ± 0.03) and IMPROVE RAM (AUC = 0.52 ± 0.03) ( < .05). The sensitivity and Yoden index of SJT RAM were higher than those of Caprini RAM, Pauda RAM, and IMPROVE RAM ( < .05), but specificity was not significantly different between the 4 models ( > .05). The SJT RAM derived from general hospitalized Chinese patients has effective and better predictive ability for internal medicine inpatients at risk of VTE.

References

Rothberg M, Hamilton A, Greene M, Fox J, Lisheba O, Milinovich A . Derivation and Validation of a Risk Factor Model to Identify Medical Inpatients at Risk for Venous Thromboembolism. Thromb Haemost. 2021; 122(7):1231-1238. DOI: 10.1055/a-1698-6506. View

Spyropoulos A, Lipardi C, Xu J, Peluso C, Spiro T, De Sanctis Y . Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended Thromboprophylaxis. TH Open. 2020; 4(1):e59-e65. PMC: 7069762. DOI: 10.1055/s-0040-1705137. View

Arpaia G, Caleffi A, Marano G, Laregina M, Erba G, Orlandini F . Padua prediction score and IMPROVE score do predict in-hospital mortality in Internal Medicine patients. Intern Emerg Med. 2020; 15(6):997-1003. DOI: 10.1007/s11739-019-02264-4. View

Hu Y, Li X, Zhou H, Lin P, Zhang J, Huang D . Comparison between the Khorana prediction score and Caprini risk assessment models for assessing the risk of venous thromboembolism in hospitalized patients with cancer: a retrospective case control study. Interact Cardiovasc Thorac Surg. 2020; 31(4):454-460. DOI: 10.1093/icvts/ivaa137. View

Wu Z, Li K, Zhu Q, Li H, Tang Z, Wang Z . Application value of D-dimer testing and Caprini risk assessment model (RAM) to predict venous thromboembolism (VTE) in Chinese non-oncological urological inpatients: a retrospective study from a tertiary hospital. Transl Androl Urol. 2020; 9(5):1904-1911. PMC: 7658137. DOI: 10.21037/tau-20-320. View

Klen J, Horvat G, Blinc A . Perioperative Prevention of Venous Thromboembolism in Abdominal Surgery Patients Based on the Caprini or the Padua Risk Score-A Single Centre Prospective Observational Study. Life (Basel). 2022; 12(11). PMC: 9694484. DOI: 10.3390/life12111843. View

Xu J, Dong J, Ren H, Chen X, Yang Y, Chen R . Incidence and risk assessment of venous thromboembolism in cancer patients admitted to intensive care unit for postoperative care. J BUON. 2018; 23(1):500-506. View

Shang M, Yan R, Wang X, Gong W, Guo Z . Comparison of 2013 and 2009 versions of Caprini risk assessment models for predicting VTE in Chinese cancer patients: a retrospective study. J Thromb Thrombolysis. 2020; 50(2):446-451. DOI: 10.1007/s11239-020-02038-2. View

Peng H, Yue L, Gao H, Zheng R, Liang P, Wang A . Risk Assessment of Deep Venous Thrombosis and Its Influencing Factors in Burn Patients. J Burn Care Res. 2019; 41(1):113-120. DOI: 10.1093/jbcr/irz121. View

10.

Schunemann H, Cushman M, Burnett A, Kahn S, Beyer-Westendorf J, Spencer F . American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018; 2(22):3198-3225. PMC: 6258910. DOI: 10.1182/bloodadvances.2018022954. View

11.

Shi J, Ye J, Zhuang X, Cheng X, Fu R, Zhao A . Application value of Caprini risk assessment model and elevated tumor-specific D-dimer level in predicting postoperative venous thromboembolism for patients undergoing surgery of gynecologic malignancies. J Obstet Gynaecol Res. 2018; 45(3):657-664. DOI: 10.1111/jog.13832. View

12.

Greco S, Zenunaj G, Bonsi B, Bella A, Lopreiato M, Luciani F . SARS-CoV-2 and finding of vein thrombosis: can IMPROVE and IMPROVEDD scores predict COVID-19 outcomes?. Eur Rev Med Pharmacol Sci. 2021; 25(4):2123-2130. DOI: 10.26355/eurrev_202102_25118. View

13.

Zhai Z, Kan Q, Li W, Qin X, Qu J, Shi Y . VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients: The Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study. Chest. 2018; 155(1):114-122. DOI: 10.1016/j.chest.2018.09.020. View

14.

Kahn S, Lim W, Dunn A, Cushman M, Dentali F, Akl E . Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2 Suppl):e195S-e226S. PMC: 3278052. DOI: 10.1378/chest.11-2296. View

15.

Kandagatla P, Goranta S, Antoine H, Marashi S, Schmoekel N, Gupta A . PADUA score as a predictor for pulmonary embolism: a potential strategy for reducing unnecessary imaging. J Thromb Thrombolysis. 2019; 47(4):566-571. DOI: 10.1007/s11239-018-01801-w. View

16.

Asmamaw M, Hungnaw W, Motbainor A, Kedir H, Tadesse T . Incidence of thromboembolism and thromboprophylaxis in medical patients admitted to specialized hospital in Ethiopia using Padua prediction score. SAGE Open Med. 2022; 10:20503121221079488. PMC: 8864278. DOI: 10.1177/20503121221079488. View

17.

Zhou H, Hu Y, Li X, Wang L, Wang M, Xiao J . Assessment of the Risk of Venous Thromboembolism in Medical Inpatients using the Padua Prediction Score and Caprini Risk Assessment Model. J Atheroscler Thromb. 2018; 25(11):1091-1104. PMC: 6224205. DOI: 10.5551/jat.43653. View

18.

Wehmeyer A, Coetzee R, McCartney J . Venous thromboembolism risk assessment and prophylaxis in hospitalised medical patients in the Cape Town metropole, South Africa. S Afr Med J. 2022; 112(2):13506. View

19.

Zhang L, Feng X, Zhang D, Jiang C, Mei H, Wang J . Deep Vein Thrombosis in Hospitalized Patients With COVID-19 in Wuhan, China: Prevalence, Risk Factors, and Outcome. Circulation. 2020; 142(2):114-128. DOI: 10.1161/CIRCULATIONAHA.120.046702. View

20.

Song C, Shargall Y, Li H, Tian B, Chen S, Miao J . Prevalence of venous thromboembolism after lung surgery in China: a single-centre, prospective cohort study involving patients undergoing lung resections without perioperative venous thromboembolism prophylaxis†. Eur J Cardiothorac Surg. 2018; 55(3):455-460. DOI: 10.1093/ejcts/ezy323. View